Imsidolimab: Clinical Trials

6 trials of Imsidolimab, newest first

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

4 completed, 2 terminated. 6 Phase 2.

By phase and status

Phase	Trials	Status
Phase 2	6	Completed 4, Terminated 2

Follow Imsidolimab: new trials by email Literature Review of Imsidolimab trials Research Report on Imsidolimab

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Hidradenitis Suppurativa Imsidolimab, Placebo - Hidradenitis Suppurativa	Phase 2	Completed	Vanda Pharmaceuticals	149	2021-07-07	2025-09-22
A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Acne Vulgaris Imsidolimab, Placebo - Acne Vulgaris	Phase 2	Completed	Vanda Pharmaceuticals	123	2021-05-15	2025-09-22
A Study to Evaluate of the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Acneiform Rash Imsidolimab, Placebo - Acneiform Eruptions	Phase 2	Terminated	Vanda Pharmaceuticals	4	2021-05-04	2025-09-22
A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Ichthyosis Imsidolimab, placebo - Ichthyosis	Phase 2	Terminated	Vanda Pharmaceuticals	5	2021-01-25	2025-09-16
A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in Adults With Palmoplantar Pustulosis Imsidolimab, Placebo - Palmoplantar Pustulosis	Phase 2	Completed	Vanda Pharmaceuticals	59	2019-05-20	2025-09-15
A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in Adults With Generalized Pustular Psoriasis Imsidolimab - Generalized Pustular Psoriasis	Phase 2	Completed	Vanda Pharmaceuticals	8	2019-01-30	2025-09-16

Conditions studied

Sponsors

Countries

NIH funding